HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX)

CUSIP: 427746102

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 3 signals
Share change
0
SEC-reported price per share
$0.43
Number of holders
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
182,615,507

Security key

427746102

Report period

Q2 2026

Institutions

1

Top holders

1

Ownership snapshot

Top reported holders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Rubric Capital Management LP
Disclosed value leader
Rubric Capital Management LP
Comparable rows
15/15
Latest evidence
31 Mar 2026
13D/G 3/4/5 13F Lead comparable stake: 16% 13D/G row: Rubric Capital Management LP Showing 1-6 of 15 holder rows.

Quick read

Rubric Capital Management LP leads the comparable SEC ownership view at 16%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Rubric Capital Management LP's linked filing trail.
Comparable ownership Top 5
Rubric Capital Management LP 16%
Clearline Capital LP 6.7%
BlackRock, Inc. 5.5%
ORBIMED ADVISORS LLC 5.4%
Velan Capital Investment Manageme... 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Rubric Capital Management LP
13D/G 3/4/5 13F
10%+ Owner · Company
16%
$37,859,003
30,046,828 shares
+$1,192,086 15 Oct 2025
Clearline Capital LP
13D/G 13F
Company
6.7%
$18,108,154
12,235,239 shares
+$3,733,614 31 Dec 2025
BlackRock, Inc.
13F
Company
13F
5.5%
$8,086,147
10,106,422 shares
31 Mar 2026
ORBIMED ADVISORS LLC
13F
Company
13F
5.4%
$7,854,534
9,816,940 shares
31 Mar 2026
Velan Capital Investment Management LP
3/4/5 13F
Other* · Company
4.8%
from 13F
$9,675,000
4,500,000 shares
30 Jan 2023
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
4.3%
$6,248,263
7,810,329 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
1
Shares
28,409
Rows available
1
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
163
Q2 2026 holders
1
Holder diff
-162
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .